| Product Code: ETC7476374 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong`s cyclosporine import market continued to show healthy growth, with a diverse range of countries contributing to the supply chain. The top exporting countries to Hong Kong for cyclosporine in 2024 were Ireland, Belgium, China, Germany, and Singapore. Despite the presence of multiple suppliers, the market remained highly competitive with a low Herfindahl-Hirschman Index (HHI) indicating low concentration. The compound annual growth rate (CAGR) from 2020 to 2024 was a robust 11.32%, with a respectable growth rate of 4.32% from 2023 to 2024, reflecting a positive outlook for the industry in the region.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Cyclosporine Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Cyclosporine Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Cyclosporine Market - Industry Life Cycle |
3.4 Hong Kong Cyclosporine Market - Porter's Five Forces |
3.5 Hong Kong Cyclosporine Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Hong Kong Cyclosporine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Hong Kong Cyclosporine Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Hong Kong Cyclosporine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Hong Kong Cyclosporine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in Hong Kong |
4.2.2 Rising geriatric population requiring immunosuppressant therapy |
4.2.3 Growing awareness and acceptance of cyclosporine as an effective treatment option |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and distribution of cyclosporine |
4.3.2 High cost associated with cyclosporine treatment |
4.3.3 Potential side effects and risks associated with long-term use of cyclosporine |
5 Hong Kong Cyclosporine Market Trends |
6 Hong Kong Cyclosporine Market, By Types |
6.1 Hong Kong Cyclosporine Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Cyclosporine Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Hong Kong Cyclosporine Market Revenues & Volume, By Transplant Rejection Prophylaxis, 2021- 2031F |
6.1.4 Hong Kong Cyclosporine Market Revenues & Volume, By Rheumatoid Arthritis, 2021- 2031F |
6.1.5 Hong Kong Cyclosporine Market Revenues & Volume, By Psoriasis, 2021- 2031F |
6.1.6 Hong Kong Cyclosporine Market Revenues & Volume, By Autoimmune Myasthenia Gravis, 2021- 2031F |
6.1.7 Hong Kong Cyclosporine Market Revenues & Volume, By Dry Eye, 2021- 2031F |
6.1.8 Hong Kong Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Hong Kong Cyclosporine Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong Cyclosporine Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Hong Kong Cyclosporine Market Revenues & Volume, By Injectable, 2021- 2031F |
6.2.4 Hong Kong Cyclosporine Market Revenues & Volume, By Topical, 2021- 2031F |
6.3 Hong Kong Cyclosporine Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong Cyclosporine Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Hong Kong Cyclosporine Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Hong Kong Cyclosporine Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.3.5 Hong Kong Cyclosporine Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Hong Kong Cyclosporine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Hong Kong Cyclosporine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Hong Kong Cyclosporine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Hong Kong Cyclosporine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Hong Kong Cyclosporine Market Import-Export Trade Statistics |
7.1 Hong Kong Cyclosporine Market Export to Major Countries |
7.2 Hong Kong Cyclosporine Market Imports from Major Countries |
8 Hong Kong Cyclosporine Market Key Performance Indicators |
8.1 Patient adherence rate to cyclosporine therapy |
8.2 Number of new prescriptions for cyclosporine |
8.3 Average time to market for new cyclosporine formulations |
8.4 Rate of adverse events reported related to cyclosporine therapy |
9 Hong Kong Cyclosporine Market - Opportunity Assessment |
9.1 Hong Kong Cyclosporine Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Hong Kong Cyclosporine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Hong Kong Cyclosporine Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Hong Kong Cyclosporine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Hong Kong Cyclosporine Market - Competitive Landscape |
10.1 Hong Kong Cyclosporine Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Cyclosporine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |